Treeway

Treway is a clinical-stage biotechnology company with the mission of developing therapies for ALS and other neurodegenerative diseases. Founded in 2012 by two ALS patients, Treway is dedicated to developing future drugs for neurodegenerative diseases. Treway's R&D portfolio focuses primarily on ALS and Alzheimer's disease, while continuously seeking to expand therapeutic targets within the field of neurodegenerative diseases.